{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:36:17Z","timestamp":1774974977539,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Postdoctoral Science Foundation funded project","award":["2024M761211"],"award-info":[{"award-number":["2024M761211"]}]},{"name":"Nanjing Postdoctoral Science Foundation funded project","award":["2024BHS210"],"award-info":[{"award-number":["2024BHS210"]}]},{"name":"Noncommunicated Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0525700"],"award-info":[{"award-number":["2024ZD0525700"]}]},{"name":"Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University) Clinical Capacity Enhancement Project","award":["JSPH-MA-2022-5"],"award-info":[{"award-number":["JSPH-MA-2022-5"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["grants 82273152"],"award-info":[{"award-number":["grants 82273152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01007-x","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:45:19Z","timestamp":1771998319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MRI based unsuperviced clustering on MIBC reveals intratumor heterogeneity phenotypes and neoadjuvant chemotherapy efficacy"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingkai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongjie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengye","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"8","key":"1007_CR1","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.cell.2021.03.009","volume":"184","author":"SC Dentro","year":"2021","unstructured":"Dentro SC, Leshchiner I, Haase K, Tarabichi M, Wintersinger J, Deshwar AG, et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell. 2021;184(8):2239\u2013e225439.","journal-title":"Cell"},{"issue":"4","key":"1007_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: Past, Present, and the future. Cell. 2017;168(4):613\u201328.","journal-title":"Cell"},{"issue":"4","key":"1007_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk A, Janiszewska M, Polyak K. Intratumor heterogeneity: the Rosetta stone of therapy resistance. Cancer Cell. 2020;37(4):471\u201384.","journal-title":"Cancer Cell"},{"issue":"1","key":"1007_CR4","doi-asserted-by":"publisher","first-page":"e222830","DOI":"10.1148\/radiol.222830","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi Z, Huang X, Cheng Z, Xu Z, Lin H, Liu C, et al. MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer. Radiology. 2023;308(1):e222830.","journal-title":"Radiology"},{"issue":"1","key":"1007_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.annonc.2024.09.008","volume":"36","author":"CS Groeneveld","year":"2025","unstructured":"Groeneveld CS, Pfister C, Culine S, Harter V, Krucker C, Fontugne J, et al. Basal\/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial. Ann Oncol. 2025;36(1):89\u201398.","journal-title":"Ann Oncol"},{"issue":"1","key":"1007_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41585-024-00901-y","volume":"22","author":"DJ Smith","year":"2024","unstructured":"Smith DJ, Lunj S, Adamson AD, Nagarajan S, Smith TAD, Reeves KJ, et al. CRISPR-Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer. Nat Rev Urol. 2024;22(1):55\u201365.","journal-title":"Nat Rev Urol"},{"issue":"24","key":"1007_CR7","doi-asserted-by":"publisher","first-page":"2308438","DOI":"10.1002\/advs.202308438","volume":"11","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Jin W, Qian K, Ju L, Wang G, Wu K, et al. Integrative single cell atlas revealed intratumoral heterogeneity generation from an adaptive epigenetic cell state in human bladder urothelial carcinoma. Adv Sci. 2024;11(24):2308438.","journal-title":"Adv Sci"},{"issue":"6","key":"1007_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.eururo.2025.07.002","volume":"88","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Khaki AR, Redman MW, Baker KK, Ng K, Chen X, et al. Neoadjuvant pembrolizumab and accelerated Methotrexate, Vinblastine, Doxorubicin, and cisplatin in nonurothelial histologic subtypes of Muscle-invasive bladder cancer: A phase 2 trial. Eur Urol. 2025;88(6):559\u201363.","journal-title":"Eur Urol"},{"issue":"1","key":"1007_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/path.5813","volume":"256","author":"N Sirab","year":"2022","unstructured":"Sirab N, Drubay D, Maill\u00e9 P, Popova T, Ngo C, Gentien D, et al. Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer. J Pathol. 2022;256(1):108\u201318.","journal-title":"J Pathol"},{"issue":"3","key":"1007_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical imaging-Reporting and data System). Eur Urol. 2018;74(3):294\u2013306.","journal-title":"Eur Urol"},{"issue":"1","key":"1007_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/ijms25010088","volume":"25","author":"TA Qureshi","year":"2023","unstructured":"Qureshi TA, Chen X, Xie Y, Murakami K, Sakatani T, Kita Y, et al. MRI\/RNA-Seq-Based radiogenomics and artificial intelligence for more accurate staging of Muscle-Invasive bladder cancer. IJMS. 2023;25(1):88.","journal-title":"IJMS"},{"key":"1007_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.urology.2020.07.021","volume":"145","author":"SWE Cornelissen","year":"2020","unstructured":"Cornelissen SWE, Veenboer PW, Wessels FJ, Meijer RP. Diagnostic accuracy of multiparametric MRI for local staging of bladder cancer: A systematic review and Meta-Analysis. Urology. 2020;145:22\u20139.","journal-title":"Urology"},{"issue":"2","key":"1007_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than Pictures, they are data. Radiology. 2016;278(2):563\u201377.","journal-title":"Radiology"},{"issue":"4","key":"1007_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, Van Stiphout RGPM, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441\u20136.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1007_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1078-0432.CCR-14-0990","volume":"21","author":"JPB O\u2019Connor","year":"2015","unstructured":"O\u2019Connor JPB, Rose CJ, Waterton JC, Carano RAD, Parker GJM, Jackson A. Imaging intratumor heterogeneity: role in therapy Response, Resistance, and clinical outcome. Clin Cancer Res. 2015;21(2):249\u201357.","journal-title":"Clin Cancer Res"},{"key":"1007_CR16","doi-asserted-by":"crossref","unstructured":"Xie Y, Wang F, Wei J, Shen Z, Song X, Wang Y, et al. Noninvasive prognostic classification of ITH in HCC with multi-\u00adomics insights and therapeutic implications. Science Advances. 2025.","DOI":"10.1126\/sciadv.ads8323"},{"issue":"40","key":"1007_CR17","doi-asserted-by":"publisher","first-page":"eadf0837","DOI":"10.1126\/sciadv.adf0837","volume":"9","author":"GH Su","year":"2023","unstructured":"Su GH, Xiao Y, You C, Zheng RC, Zhao S, Sun SY, et al. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. Sci Adv. 2023;9(40):eadf0837.","journal-title":"Sci Adv"},{"issue":"9","key":"1007_CR18","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1002\/mco2.722","volume":"5","author":"W He","year":"2024","unstructured":"He W, Huang W, Zhang L, Wu X, Zhang S, Zhang B. Radiogenomics: bridging the gap between imaging and genomics for precision oncology. MedComm. 2024;5(9):e722.","journal-title":"MedComm"},{"issue":"3","key":"1007_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1148\/radiol.2021203281","volume":"301","author":"Q Sun","year":"2021","unstructured":"Sun Q, Chen Y, Liang C, Zhao Y, Lv X, Zou Y, et al. Biologic pathways underlying prognostic radiomics phenotypes from paired MRI and RNA sequencing in glioblastoma. Radiology. 2021;301(3):654\u201363.","journal-title":"Radiology"},{"issue":"21","key":"1007_CR20","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM Van Griethuysen","year":"2017","unstructured":"Van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to Decode the radiographic phenotype. Cancer Res. 2017;77(21):e104\u20137.","journal-title":"Cancer Res"},{"issue":"12","key":"1007_CR21","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"3","key":"1007_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, et al. Comprehensive molecular characterization of Muscle-Invasive bladder cancer. Cell. 2017;171(3):540\u2013e55625.","journal-title":"Cell"},{"issue":"2","key":"1007_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, et al. Identification of distinct basal and luminal subtypes of Muscle-Invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25(2):152\u201365.","journal-title":"Cancer Cell"},{"issue":"1","key":"1007_CR24","doi-asserted-by":"publisher","first-page":"21186","DOI":"10.1038\/s41598-021-00628-5","volume":"11","author":"T Bejrananda","year":"2021","unstructured":"Bejrananda T, Kanjanapradit K, Saetang J, Sangkhathat S. Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5\/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer. Sci Rep. 2021;11(1):21186.","journal-title":"Sci Rep"},{"key":"1007_CR25","doi-asserted-by":"crossref","unstructured":"Lin P, Wen D yue, Chen L, Li X, Li S hua, Yan H biao, et al. A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma. Eur Radiol. 2020;30(1):547\u201357.","DOI":"10.1007\/s00330-019-06371-w"},{"issue":"1","key":"1007_CR26","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJWL Aerts","year":"2014","unstructured":"Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Carvalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5(1):4006.","journal-title":"Nat Commun"},{"key":"1007_CR27","doi-asserted-by":"publisher","first-page":"722642","DOI":"10.3389\/fimmu.2021.722642","volume":"12","author":"F Ye","year":"2021","unstructured":"Ye F, Hu Y, Gao J, Liang Y, Liu Y, Ou Y, et al. Radiogenomics map reveals the landscape of m6A methylation modification pattern in bladder cancer. Front Immunol. 2021;12:722642.","journal-title":"Front Immunol"},{"issue":"1","key":"1007_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/JS9.0000000000001999","volume":"111","author":"K Chen","year":"2025","unstructured":"Chen K, Li X, Liu L, Wang B, Liang W, Chen J, et al. Correlation of noninvasive imaging of tumour-infiltrating lymphocytes with survival and BCG immunotherapy response in patients with bladder cancer: a multicentre cohort study. Int J Surg. 2025;111(1):920\u201331.","journal-title":"Int J Surg"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01007-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01007-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01007-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:55:43Z","timestamp":1774968943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01007-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1007"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01007-x","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the First Affiliated Hospital with Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained from all participants (or their parents\/legal guardians in the case of children) in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}